Study finds that Beta-Blockers with high sialyzability have potential for treating hemodialysis patients
Chronic hemodialysis patients face heightened cardiovascular risks, necessitating a nuanced approach to medication selection. Beta-blockers, known for their cardioprotective effect...
Read →